Report Categories Report Categories

Report Categories

industry Category

All

Total: 2 records, 1 pages

Global Group A and Group C Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2024-2030

date 02 Mar 2024

date Pharma & Healthcare

new_biaoQian Group A and Group C Meningococcal Polysaccharide Vaccine

The global Group A and Group C Meningococcal Polysaccharide Vaccine market size is expected to reach $ 430.2 million by 2030, rising at a market growth of 5.6% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Group A and Group C Meningococcal Polysaccharide Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 29 Jan 2024

date Pharma & Healthcare

new_biaoQian Group A and Group C Meningococcal Polysaccharide Vaccine

According to our (Global Info Research) latest study, the global Group A and Group C Meningococcal Polysaccharide Vaccine market size was valued at USD 293.3 million in 2023 and is forecast to a readjusted size of USD 430.2 million by 2030 with a CAGR of 5.6% during review period.

USD3480.00

Add To Cart

Add To Cart

The global Group A and Group C Meningococcal Polysaccharide Vaccine market size is expected to reach $ 430.2 million by 2030, rising at a market growth of 5.6% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

According to our (Global Info Research) latest study, the global Group A and Group C Meningococcal Polysaccharide Vaccine market size was valued at USD 293.3 million in 2023 and is forecast to a readjusted size of USD 430.2 million by 2030 with a CAGR of 5.6% during review period.

USD3480.00

addToCart

Add To Cart